Landscapes / Companies
Bioray Laboratories not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 6 in all
Trials
2 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | — | |||
| Also tested for | Beta-Thalassemia | ||||
| Open drug page | |||||
— |
Phase 1 | 20 Nov 2026soonPhase 1 trial completes | |||
| Next date | 20 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Non-hodgkin Lymphoma,B Cell | ||||
| Open drug page | |||||
About
- No active trial
- CD19-UCART, LIGHT-PSMA-CART cells, Universal BCMA-CD19 CART, β-globin restored autologous HSC
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021